Literature DB >> 2901952

Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.

C R King1, I Borrello, F Bellot, P Comoglio, J Schlessinger.   

Abstract

The epidermal growth factor receptor (EGF-R) and the erbB-2 proto-oncogene product protein are closely related by their structural homology and their shared enzymatic activity as autophosphorylating tyrosine kinases. We show that in mammary tumor cells (SK-BR-3) EGF causes a rapid increase in tyrosine phosphorylation of the erbB-2 protein. Phosphorylation of erbB-2 does not occur in cells lacking the EGF-R (MDA-MB-453). Phosphorylation of erbB-2 in SK-BR-3 cells is blocked if EGF is prevented from interacting with its receptor by specific monoclonal antibodies. While EGF induces the down-regulation of its receptor in SK-BR-3 cells, EGF has no effect on the stability of the erbB-2 protein. This result suggests that the erbB-2 protein is a substrate of the EGF-R and indicates the possibility of communication between these two proteins early in the signal transduction process.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901952      PMCID: PMC457148          DOI: 10.1002/j.1460-2075.1988.tb02991.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

Authors:  J Filmus; M N Pollak; R Cailleau; R N Buick
Journal:  Biochem Biophys Res Commun       Date:  1985-04-30       Impact factor: 3.575

2.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

Authors:  C J Sherr; C W Rettenmier; R Sacca; M F Roussel; A T Look; E R Stanley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

3.  Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. Immunopurification using a monoclonal antibody to phosphotyrosine.

Authors:  A R Frackelton; P M Tremble; L T Williams
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Amiloride directly inhibits growth factor receptor tyrosine kinase activity.

Authors:  R J Davis; M P Czech
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

6.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein.

Authors:  R M Kris; I Lax; W Gullick; M D Waterfield; A Ullrich; M Fridkin; J Schlessinger
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

7.  Insulin-like growth factor-I (IGF-I) stimulates tyrosine kinase activity in purified receptors from a rat liver cell line.

Authors:  Y Zick; N Sasaki; R W Rees-Jones; G Grunberger; S P Nissley; M M Rechler
Journal:  Biochem Biophys Res Commun       Date:  1984-02-29       Impact factor: 3.575

8.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

Authors:  C R King; M H Kraus; S A Aaronson
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

9.  A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

Authors:  K Semba; N Kamata; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.

Authors:  G T Merlino; Y H Xu; S Ishii; A J Clark; K Semba; K Toyoshima; T Yamamoto; I Pastan
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

View more
  55 in total

1.  Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

Authors:  R J Epstein; B J Druker; T M Roberts; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

Authors:  R Pinkas-Kramarski; L Soussan; H Waterman; G Levkowitz; I Alroy; L Klapper; S Lavi; R Seger; B J Ratzkin; M Sela; Y Yarden
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

3.  Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.

Authors:  Y Yarden; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor.

Authors:  Estelle Rousselet; Suzanne Benjannet; Edwidge Marcinkiewicz; Marie-Claude Asselin; Claude Lazure; Nabil G Seidah
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

5.  MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors:  Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

6.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.

Authors:  E Tzahar; H Waterman; X Chen; G Levkowitz; D Karunagaran; S Lavi; B J Ratzkin; Y Yarden
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity.

Authors:  S M Hernández-Sotomayor; C L Arteaga; C Soler; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 8.  Molecular biology of breast carcinoma.

Authors:  D el-Ashry; M E Lippman
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

9.  In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.

Authors:  C Liu; M S Tsao
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

10.  Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells.

Authors:  Daniel J Barr; Anne G Ostermeyer-Fay; Rachel A Matundan; Deborah A Brown
Journal:  J Cell Sci       Date:  2008-09-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.